Is the C3a receptor antagonist SB290157 a useful pharmacological tool?

John D Lee¹, Stephen M Taylor¹, Trent M Woodruff^{1

2}

Affiliations

¹ School of Biomedical Sciences, The University of Queensland, St Lucia, Queensland, Australia.
² Queensland Brain Institute, The University of Queensland, St Lucia, Queensland, Australia.

Comment

John D Lee et al. Br J Pharmacol. 2020 Dec.

. 2020 Dec;177(24):5677-5678.

doi: 10.1111/bph.15264. Epub 2020 Oct 18.

John D Lee¹, Stephen M Taylor¹, Trent M Woodruff^{1

2}

¹ School of Biomedical Sciences, The University of Queensland, St Lucia, Queensland, Australia.
² Queensland Brain Institute, The University of Queensland, St Lucia, Queensland, Australia.

No abstract available

Comment on

C3a receptor antagonist therapy is protective with or without thrombolysis in murine thromboembolic stroke.
Ahmad S, Pandya C, Kindelin A, Bhatia K, Chaudhary R, Dwivedi AK, Eschbacher JM, Liu Q, Waters MF, Hoda MN, Ducruet AF. Ahmad S, et al. Br J Pharmacol. 2020 Jun;177(11):2466-2477. doi: 10.1111/bph.14989. Epub 2020 Mar 4. Br J Pharmacol. 2020. PMID: 31975437 Free PMC article.

1. Ahmad, S. , Pandya, C. , Kindelin, A. , Bhatia, K. , Chaudhary, R. , Dwivedi, A. K. , … Ducruet, A. F. (2020). C3a receptor antagonist therapy is protective with or without thrombolysis in murine thromboembolic stroke. British Journal of Pharmacology, 177, 2466–2477. 10.1111/bph.14989 - DOI - PMC - PubMed
1. Busche, M. N. , & Stahl, G. L. (2010). Role of the complement components C5 and C3a in a mouse model of myocardial ischemia and reperfusion injury. German Medical Science, 8, Doc20. - PMC - PubMed
1. Coulthard, L. G. , & Woodruff, T. M. (2015). Is the complement activation product C3a a proinflammatory molecule? Re‐evaluating the evidence and the myth. Journal of Immunology, 194, 3542–3548. - PubMed
1. Li, X. X. , Lee, J. D. , Kumar, V. , & Woodruff, T. M. (2020). The ‘C3aR antagonist’ SB290157 is a partial C5aR2 agonist. bioRxiv 10.1101/2020.08.01.232090. - DOI - PMC - PubMed
1. Mathieu, M. C. , Sawyer, N. , Greig, G. M. , Hamel, M. , Kargman, S. , Ducharme, Y. , … Therien, A. G. (2005). The C3a receptor antagonist SB 290157 has agonist activity. Immunology Letters, 100, 139–145. 10.1016/j.imlet.2005.03.003 - DOI - PubMed